Plante Moran Financial Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Plante Moran Financial Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$607	Buy	+24	New	+$528	﹤0.01%	1063
2019 Q4	–	Sell	-1,000	Closed	-$36K	–	739
2019 Q3	$36K	Buy	+1,000	New	+$30.3K	0.01%	396
2016 Q2	–	Sell	-32	Closed	-$1K	–	897
2016 Q1	$1K	Buy	+32	New	+$698	﹤0.01%	795
2013 Q4	–	Sell	-83	Closed	-$2K	–	682
2013 Q3	$2K	Buy	+83	New	+$1.74K	﹤0.01%	547

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Plante Moran Financial Advisors's ACAD Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 24 shares worth $607. The stake represents ﹤0.01% of the portfolio and ranks #1063 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in ACAD as recently as Q3 2019.

Plante Moran Financial Advisors first reported a position in ACAD in Q3 2013 and has held it in 4 quarters since. The position peaked at $36K in Q3 2019. 352 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Plante Moran Financial Advisors held 24 shares of Acadia Pharmaceuticals worth $607 as of Q2 2026.
Acadia Pharmaceuticals was a new Plante Moran Financial Advisors position in Q2 2026.
Acadia Pharmaceuticals made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1063 holding.
Plante Moran Financial Advisors first reported a position in Acadia Pharmaceuticals in Q3 2013 and has held it in 4 quarters since.
Plante Moran Financial Advisors's Acadia Pharmaceuticals position peaked at $36K in Q3 2019.
352 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.